Saturday, September 23, 2023
Saturday, September 23, 2023

Satellite Healthcare Names Eric Weinhandl Senior Director of Analytics and Home Therapies

Satellite Healthcare is pleased to announce that Eric Weinhandl, a highly respected epidemiologist within the home dialysis arena, will be joining Satellite Healthcare as Senior Director of Analytics and Home Therapies.

Eric’s deep and rich background researching chronic kidney disease, in particular dialysis and related pharmaceuticals, will advance our home dialysis analytics capabilities and contribute to advancing clinical initiatives. Eric is recognized internationally for his deep knowledge of home dialysis and unique expertise in home data analytics. He is a sought-after speaker at national and international meetings and is widely published in the field of ESKD.

Eric Weinhandl will be an integral part of Satellite’s focus on innovation, and advancing the company’s analytics and quality strategies. He will work closely with Sumi Sun, Vice President of Analytics and Quality, Dr. Brigitte Schiller, as well as the Medical Clinical Affairs, Research and Operations teams across the organization.

Eric has significantly influenced the organizations for which he has worked, including the United States Renal Data System (USRDS), NxStage/Fresenius Medical Care, and, most recently, Chronic Disease Research Group, where he served as Director of Home Dialysis Research. He has conducted studies in partnership with Amgen, Baxter, DaVita, NxStage, and the Peer Kidney Care Initiative among many others.

Eric graduated from St. Olaf College as valedictorian with a B.A. in Mathematics and attained an M.S. degree in biostatistics and a Ph.D. in epidemiology from the University of Minnesota. He will join Satellite Healthcare on December 1, 2021.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer

Brian Schubmehl brings more than two decades of diverse and senior global leadership expertise that has spanned private equity, startup, and publicly traded organizations.

Joseph Schwab MD, MS, to Lead Spine-Oncology Program and Center for Surgical Technology and AI Research at Cedars-Sinai

Joseph Schwab combines extensive experience in translational research and clinical trials with a record of high-quality clinical care. He specializes in the management of benign and malignant bone tumors as well as spinal disorders, including stenoses and myelopathy. His expertise will drive transformative advancements in spine oncology and surgical technology at Cedars-Sinai.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Adam Hodges brings more than 20 years of commercialization experience in the medical device industry. Most recently, Adam was Vice President of Sales at SIA Health, leading the commercial acceleration of DuraSorb®, which was acquired by Integra LifeSciences (NASDAQ: IART) in December 2022. During his tenure at SIA, Adam grew sales revenue by more than 5X in less than two years and previously served concurrent roles of Vice President of Strategic Accounts and Regional Business Director.

By using this website you agree to accept Medical Device News Magazine Privacy Policy